{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:29:46Z","timestamp":1795044586662,"version":"4.10.2"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001353","name":"NKF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001353","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Keryx Biopharmaceuticals"},{"DOI":"10.13039\/501100002066","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MD000182"],"award-info":[{"award-number":["MD000182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000124"],"award-info":[{"award-number":["UL1TR000124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AG021684"],"award-info":[{"award-number":["P30AG021684"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1053\/j.ajkd.2018.06.031","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T18:50:48Z","timestamp":1538765448000},"page":"834-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation"],"prefix":"10.1053","volume":"72","author":[{"given":"Michal L.","family":"Melamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chonchol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Scialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Thadhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.ajkd.2014.05.018","article-title":"25-Hydroxyvitamin D testing and supplementation in CKD: an\u00a0NKF-KDOQI controversies report","volume":"64","author":"Kramer","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000450766","article-title":"Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"44","author":"Sprague","year":"2016","journal-title":"Am J Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2018.06.031_bib4","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1017\/S000711451600427X","article-title":"Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial","volume":"116","author":"Wetmore","year":"2016","journal-title":"Br J Nutr"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.031_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib6","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.05781207","article-title":"Hypovitaminosis D in chronic kidney disease","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.031_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.ki.5002002","article-title":"25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and\u00a0Nutrition Examination Survey","volume":"71","author":"Chonchol","year":"2007","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.031_bib9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1523-1755.1999.0550031019.x","article-title":"Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure","volume":"55","author":"Ishimura","year":"1999","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","article-title":"Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe\u00a0renal failure","volume":"67","author":"Pitts","year":"1988","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.031_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1532-5415.2007.01048.x","article-title":"A\u00a0higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study","volume":"55","author":"Broe","year":"2007","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.031_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2105\/AJPH.2004.045260","article-title":"The role of vitamin D in cancer prevention","volume":"96","author":"Garland","year":"2006","journal-title":"Am J Public Health"},{"issue":"9471","key":"10.1053\/j.ajkd.2018.06.031_bib13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(05)63013-9","article-title":"Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium or vitamin D, RECORD): a randomised placebo-controlled trial","volume":"365","author":"Grant","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.031_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/79.3.362","article-title":"Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis","volume":"79","author":"Holick","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1053\/j.ajkd.2018.06.031_bib15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/jama.2017.2115","article-title":"Effect of vitamin D and calcium supplementation on cancer incidence in older\u00a0women: a randomized clinical trial","volume":"317","author":"Lappe","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"10.1053\/j.ajkd.2018.06.031_bib16","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3945\/ajcn.117.152736","article-title":"Vitamin D supplementation has no effect on insulin sensitivity or secretion in vitamin D-deficient, overweight or obese adults: a randomized placebo-controlled trial","volume":"105","author":"Mousa","year":"2017","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib17","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2215\/CJN.01160308","article-title":"Vitamin D in health and disease","volume":"3","author":"Heaney","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2018.06.031_bib18","series-title":"Dietary Reference Intakes for Calcium and Vitamin D","year":"2011"},{"issue":"7","key":"10.1053\/j.ajkd.2018.06.031_bib19","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1053\/j.ajkd.2018.06.031_bib20","first-page":"1127","article-title":"Toward a physiological referent for the vitamin D requirement","volume":"37","author":"Heaney","year":"2014","journal-title":"J\u00a0Endocrin Invest"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000081023","article-title":"Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study","volume":"24","author":"Gonzalez","year":"2004","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ajcn\/65.1.67","article-title":"Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women","volume":"65","author":"Dawson-Hughes","year":"1997","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1053\/j.ajkd.2018.06.031_bib23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM199803193381201","article-title":"Hypovitaminosis D in medical inpatients","volume":"338","author":"Thomas","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1525-139X.2005.18402.x","article-title":"Vitamin D for health and in chronic kidney disease","volume":"18","author":"Holick","year":"2005","journal-title":"Semin Dial"},{"issue":"4 suppl 3","key":"10.1053\/j.ajkd.2018.06.031_bib25","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2018.06.031_bib26","first-page":"1313","article-title":"Defective photoproduction of cholecalciferol in normal and uremic humans","volume":"114","author":"Jacob","year":"1984","journal-title":"J\u00a0Nutr"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.031_bib27","first-page":"325","article-title":"Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome","volume":"99","author":"Sato","year":"1982","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1053\/j.ajkd.2018.06.031_bib28","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.031_bib29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clnu.2017.04.020","article-title":"Serum 24,25-dihydroxyvitamin D3 response to native vitamin D2 and D3 supplementation in patients with chronic kidney disease on hemodialysis","volume":"37","author":"Graeff-Armas","year":"2018","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.031_bib30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1373\/clinchem.2014.222521","article-title":"Vitamin D: the more we know, the less we know","volume":"61","author":"Scott","year":"2015","journal-title":"Clin Chem"},{"issue":"7","key":"10.1053\/j.ajkd.2018.06.031_bib31","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/jbmr.3135","article-title":"Improved screening test for idiopathic infantile hypercalcemia confirms residual levels of serum 24,25-(OH)2 D3 in affected patients","volume":"32","author":"Kaufmann","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib32","doi-asserted-by":"crossref","first-page":"e0195427","DOI":"10.1371\/journal.pone.0195427","article-title":"Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3","volume":"13","author":"Kagi","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.031_bib33","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2215\/CJN.00530117","article-title":"Effects of\u00a0vitamin D2 supplementation on vitamin D3 metabolism in health and CKD","volume":"12","author":"Batacchi","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jcem-53-1-139","article-title":"Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer","volume":"53","author":"Chesney","year":"1981","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ajkd.2018.06.031_bib35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1017\/S0007114517000538","article-title":"Common genetic variants are associated with lower serum 25-hydroxyvitamin D concentrations across the year among children at northern latitudes","volume":"117","author":"Petersen","year":"2017","journal-title":"Br J Nutr"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semnephrol.2013.07.006","article-title":"Fibroblast growth factor 23, vitamin D, and health disparities among African Americans with chronic kidney disease","volume":"33","author":"Saxena","year":"2013","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nut.2011.10.015","article-title":"25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: the NHANES-III linked mortality files","volume":"28","author":"Michos","year":"2012","journal-title":"Nutrition"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.031_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.2013.7229","article-title":"Race\/ethnicity, serum 25-hydroxyvitamin D, and heart disease","volume":"310","author":"Norris","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.031_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2013.7228","article-title":"Racial differences\u00a0in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events","volume":"310","author":"Robinson-Cohen","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5414\/CNP70312","article-title":"Race is a major determinant of secondary hyperparathyroidism in uremic patients: comparative study of blacks and Hispanics","volume":"70","author":"Omije","year":"2008","journal-title":"Clin Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2018.06.031_bib41","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/jbmr.177","article-title":"Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients","volume":"25","author":"Kalantar-Zadeh","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib42","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0272-6386(99)70430-0","article-title":"Racial differences in bone mineral density and bone loss among end-stage renal disease patients","volume":"33","author":"Stehman-Breen","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1053\/j.ajkd.2013.02.368","article-title":"Trends in hip fracture rates in US hemodialysis patients, 1993-2010","volume":"62","author":"Arneson","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1159\/000369039","article-title":"Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis","volume":"40","author":"Mathew","year":"2014","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2018.06.031_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.07020711","article-title":"Racial differences in markers of mineral metabolism in advanced chronic kidney disease","volume":"7","author":"Jovanovich","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000438999","article-title":"Race, mineral homeostasis and mortality in patients with end-stage renal disease on dialysis","volume":"42","author":"Scialla","year":"2015","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.031_bib48","first-page":"880","article-title":"Vitamin D-binding protein and vitamin D in blacks and whites","volume":"370","author":"Powe","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2018.06.031_bib49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1373\/clinchem.2015.240051","article-title":"24,25-Dihydroxyvitamin D3 and vitamin D status of community-dwelling black and white Americans","volume":"61","author":"Berg","year":"2015","journal-title":"Clin Chem"},{"issue":"4466","key":"10.1053\/j.ajkd.2018.06.031_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1126\/science.6251551","article-title":"Photosynthesis of previtamin D3 in human skin and the physiologic consequences","volume":"210","author":"Holick","year":"1980","journal-title":"Science"},{"issue":"10","key":"10.1053\/j.ajkd.2018.06.031_bib51","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.transproceed.2016.09.050","article-title":"Natural history of serum calcium and parathyroid hormone following renal transplantation","volume":"48","author":"Al-Moasseb","year":"2016","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1053\/j.ajkd.2018.06.031_bib52","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2009030283","article-title":"25-Hydroxyvitamin D levels, race, and the progression of kidney disease","volume":"20","author":"Melamed","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib53","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/dc12-0962","article-title":"Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies","volume":"36","author":"Song","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2018.06.031_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.031_bib56","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/jcb.20875","article-title":"Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization","volume":"99","author":"van Driel","year":"2006","journal-title":"J\u00a0Cell Biochem"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib57","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.ki.5000394","article-title":"25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells","volume":"70","author":"Ritter","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.03940510","article-title":"Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials","volume":"6","author":"Kandula","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5 suppl 5","key":"10.1053\/j.ajkd.2018.06.031_bib59","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1053\/ajkd.2001.28112","article-title":"Paricalcitol dosing according to body weight or severity of hyperparathyroidism: a double-blind, multicenter, randomized study","volume":"38","author":"Martin","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2011.06.027","article-title":"Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial","volume":"59","author":"Kovesdy","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2018.06.031_bib61","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2018.06.031_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cct.2015.12.022","article-title":"Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)","volume":"47","author":"Bassuk","year":"2016","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease","volume":"33","author":"Manson","year":"2012","journal-title":"Contemp Clin Trials"},{"issue":"pt B","key":"10.1053\/j.ajkd.2018.06.031_bib64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jsbmb.2015.04.006","article-title":"Update on the Vitamin D and OmegA-3 trial (VITAL)","volume":"155","author":"Pradhan","year":"2016","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.031_bib65","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2215\/CJN.03000311","article-title":"Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis","volume":"7","author":"Cheng","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.031_bib66","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/ndt\/gft227","article-title":"Effects\u00a0of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study","volume":"28","author":"Coyne","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib67","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3945\/ajcn.110.003350","article-title":"Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements","volume":"94","author":"Wallace","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1053\/j.ajkd.2018.06.031_bib68","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/aje\/kwq005","article-title":"Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study","volume":"171","author":"Jorde","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"15","key":"10.1053\/j.ajkd.2018.06.031_bib69","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-Hydroxyvitamin D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1053\/j.ajkd.2018.06.031_bib70","doi-asserted-by":"crossref","first-page":"E2133","DOI":"10.1210\/jc.2014-1389","article-title":"Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial","volume":"99","author":"Barry","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1053\/j.ajkd.2018.06.031_bib71","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00198-010-1383-2","article-title":"Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey","volume":"22","author":"Guti\u00e9rrez","year":"2011","journal-title":"Osteoporos Int"},{"issue":"18","key":"10.1053\/j.ajkd.2018.06.031_bib72","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1001\/jama.2012.17304","article-title":"Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes","volume":"308","author":"Levin","year":"2012","journal-title":"JAMA"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.031_bib73","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-156-9-201205010-00004","article-title":"Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older\u00a0adults: a cohort study","volume":"156","author":"de Boer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.031_bib74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ejcn.2009.140","article-title":"Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults","volume":"64","author":"Semba","year":"2010","journal-title":"Eur J Clin Nutr"},{"issue":"9752","key":"10.1053\/j.ajkd.2018.06.031_bib75","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2213-8587(13)70212-2","article-title":"The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis","volume":"2","author":"Bolland","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1053\/j.ajkd.2018.06.031_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1903","article-title":"Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies","volume":"348","author":"Chowdhury","year":"2014","journal-title":"BMJ"},{"issue":"9912","key":"10.1053\/j.ajkd.2018.06.031_bib78","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(13)61647-5","article-title":"Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis","volume":"383","author":"Reid","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","article-title":"Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD","volume":"50","author":"Al-Aly","year":"2007","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.031_bib80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD","volume":"47","author":"Coyne","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.031_bib81","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2215\/CJN.10661013","article-title":"A\u00a0randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD","volume":"9","author":"Coyne","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2018.06.031_bib82","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2013030203","article-title":"Active vitamin D treatment for reduction of residual proteinuria: a systematic review","volume":"24","author":"de Borst","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib83","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2018.06.031_bib84","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib85","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11255-018-1829-6","article-title":"Vitamin D supplementation improves endothelial dysfunction in patients with non-dialysis chronic kidney disease","volume":"50","author":"Zhang","year":"2018","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.031_bib86","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.114.03748","article-title":"Paricalcitol and endothelial function in chronic kidney disease trial","volume":"64","author":"Zoccali","year":"2014","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib87","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1681\/ASN.2016040407","article-title":"Effects of vitamin D receptor activation and dietary sodium restriction on residual albuminuria in CKD: the ViRTUE-CKD Trial","volume":"28","author":"Keyzer","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2213-8587(17)30359-5","article-title":"Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial","volume":"6","author":"Parvanova","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.031_bib89","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10791016","article-title":"Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD","volume":"12","author":"Levin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12882-017-0436-6","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria","volume":"18","author":"Susantitaphong","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1053\/j.ajkd.2018.06.031_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g6330","article-title":"Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts","volume":"349","author":"Afzal","year":"2014","journal-title":"BMJ"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.031_bib92","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-8587(14)70113-5","article-title":"Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study","volume":"2","author":"Vimaleswaran","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib93","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and\u00a0risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"issue":"7","key":"10.1053\/j.ajkd.2018.06.031_bib94","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCULATIONAHA.106.673491","article-title":"Calcium\/vitamin D supplementation and cardiovascular events","volume":"115","author":"Hsia","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib95","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12882-017-0576-8","article-title":"Vitamin D receptor activation reduces inflammatory cytokines and plasma microRNAs in moderate chronic kidney\u00a0disease - a randomized trial","volume":"18","author":"Mansouri","year":"2017","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.031_bib96","first-page":"506","article-title":"Activation of Nrf2-antioxidant signaling by 1,25-dihydroxycholecalciferol prevents leptin-induced oxidative stress and inflammation in human endothelial cells","volume":"147","author":"Teixeira","year":"2017","journal-title":"J\u00a0Nutr"},{"issue":"13","key":"10.1053\/j.ajkd.2018.06.031_bib97","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.0000160353.27927.70","article-title":"25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and\u00a0estrogenic compounds","volume":"111","author":"Somjen","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.031_bib98","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1-2","key":"10.1053\/j.ajkd.2018.06.031_bib99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mce.2003.11.017","article-title":"Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase","volume":"215","author":"Hewison","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"4423","key":"10.1053\/j.ajkd.2018.06.031_bib100","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1126\/science.505004","article-title":"Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid","volume":"206","author":"Stumpf","year":"1979","journal-title":"Science"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.031_bib101","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000430813","article-title":"Ergocalciferol versus cholecalciferol for nutritional vitamin D replacement in CKD","volume":"130","author":"Mangoo-Karim","year":"2015","journal-title":"Nephron"},{"key":"10.1053\/j.ajkd.2018.06.031_bib102","first-page":"CD007470","article-title":"Vitamin D supplementation for prevention of mortality in adults","volume":"1","author":"Bjelakovic","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1053\/j.ajkd.2018.06.031_bib103","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1210\/jc.2016-1871","article-title":"Effects of high-dose vitamin D2 versus D3 on total and free 25-hydroxyvitamin D and markers of\u00a0calcium balance","volume":"101","author":"Shieh","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618308394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618308394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:15:25Z","timestamp":1759461325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638618308394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0272638618308394"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.031","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}